Same Indication

Irbesartan vs Methotrexate

Irbesartan vs Methotrexate: Overview

This comparison examines the pharmacological differences between Irbesartan and Methotrexate.

Mechanism of Action

Irbesartan: Selective non-competitive angiotensin II type 1 receptor antagonist.

Methotrexate: Dihydrofolate reductase inhibitor.

Pharmacokinetics

Half-life: Irbesartan β€” 11-15 hours; Methotrexate β€” 3-10 hours.

Chemical Properties

Molecular Formula: Irbesartan β€” C25H28N6O; Methotrexate β€” C20H22N8O5.

Molecular Weight: Irbesartan β€” 428.5320 g/mol; Methotrexate β€” 454.4400 g/mol.

Type: Irbesartan β€” Small molecule; Methotrexate β€” Small molecule.